 |
| |
 |
|
|
With excellent research staff and nation¡¯s
best expertise, Macrogen provides distinguished services to
many researchers all around the world. Macrogen¡¯s dedicated
research efforts keep producing successful completion of large
projects such as Korea Genome BAC Clone Map and Zymomonas
mobilis Genome Project.
|
| |
 |
|
|
As the first company having introduced Oligochip
products in Korea, Macrogen has been developing and providing
DNA Chip total solution to many customers all around the world.
Macrogen develops and sells various product lines such as
MacArray¢â Express Oligochip capable of identifying the degree
of gene expression and MacArray¢â Karyo capable of diagnosing
human chromosome aberration, using microbes, mice, and human
tissue samples. In addition, the company designs and produces
MacProbe¢â consisting of various FISH Probe products.
|
| |
 |
|
|
Macrogen, based on several years of experiences
and technologies accumulated from Seoul National University
Transgenic Research Institute, its predecessor, has established
world-class transgenic and gene knockout technologies and
services. With advanced SPF facility newly set up, Macrogen
is focusing on functional genomics research while providing
transgenic/knockout mice covering the entire process ranging
from vector design to delivery.
|
| |
 |
|
Lentiviral vector systems are efficiently used for a gene delivery in vitro and in vivo for long-term and stable gene expression. Lentiviruses, a subgroup of retroviruses, can be used for an ideal tool for delivering exogenous genes to target cells because of their ability for stable, efficient integration into the genome of both dividing and non-dividing cells. Therefore, it could be expected to be widely used for inherited and degenerative diseases.
LentiVector Institute (LVI) in MACROGEN is now providing customized recombinant lentivirus production services for researchers to use high-titer virus particles easily.
For safety concerns, non-primate lentiviruses are preferred for use in gene therapy. LVI is developing a non-primate lentiviral vector, CAEV (Caprine Arthritisris Encephalitis Virus) vector, to invent novel and effective gene delivery technology. The developed CAEV vector system is currently on the application for patents in US, EP, Japan, and China as well as Korea.
|
| |
 |
|
|
With Korea¡¯s largest gene database with its
world-recognized core competences, Macrogen has obtained excellent
results in the field of Bioinformatics. Furthermore, with
excellent BT & IT human resources at Bioinformatics Research
Center, Macrogen provides a total of 6 services including
database construction, Genome Research, and Bioinformatics
comprehensive analysis system consulting services.
|
| |
| |
|